Tandem Diabetes Care

Yahoo Finance • 14 hours ago

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 2 days ago

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting fr... Full story

Yahoo Finance • 9 days ago

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. The pharmaceutical and b... Full story

Yahoo Finance • 10 days ago

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

LOS ANGELES, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) in... Full story

Yahoo Finance • 11 days ago

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) on behalf of investors concerning the Company’s possibl... Full story

Yahoo Finance • 12 days ago

Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States

SAN DIEGO, September 29, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin deli... Full story

Yahoo Finance • 2 months ago

Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report,... Full story

Yahoo Finance • 2 months ago

Tandem Diabetes upgraded at Citi on risk-reward setup

[Wall Street New York stock exchange stock market] alexsl Tandem Diabetes Care (NASDAQ:TNDM [https://seekingalpha.com/symbol/TNDM]) traded higher on Tuesday after Citi upgraded the insulin pump maker to Neutral from Sell, citing a shift i... Full story

Yahoo Finance • 2 months ago

Tandem Diabetes Care Inc. (TNDM) - Product Pipeline Analysis Report 2025

Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. Tandem Diabetes Care Inc, a leading provider in the realm of... Full story

Yahoo Finance • 2 months ago

Piper Sandler downgrades Tandem Diabetes stock on weak domestic outlook

Investing.com - Piper Sandler downgraded Tandem Diabetes Care (NASDAQ:TNDM) from Overweight to Neutral on Thursday, while significantly reducing its price target to $14.00 from $30.00. The stock, currently trading at $14.39, has fallen ove... Full story

Yahoo Finance • 2 months ago

Tandem Diabetes Care Inc (NASDAQ:TNDM) Reports Mixed Q2 2025 Results with Revenue Miss and Wider Loss

Tandem Diabetes Care Inc (NASDAQ:TNDM [https://www.chartmill.com/stock/quote/TNDM]) reported mixed second-quarter 2025 results, with revenue slightly below analyst expectations and a wider-than-anticipated loss per share. The company also... Full story

Yahoo Finance • 3 months ago

Tandem Diabetes Care stock hits 52-week low at 14.86 USD

Tandem Diabetes Care (NASDAQ:TNDM) Inc’s stock has reached a new 52-week low, trading at 14.86 USD, down significantly from its 52-week high of 47.60 USD. This milestone comes amidst a challenging year for the company, with InvestingPro da... Full story

Yahoo Finance • 3 months ago

Abbott Labs stock rating reiterated by Piper Sandler ahead of Q2 earnings

Investing.com - Piper Sandler has reiterated an Overweight rating and $150.00 price target on Abbott Labs (NYSE:ABT), currently trading near its 52-week high at $131.60, ahead of the company’s second-quarter earnings report expected on Jul... Full story

Yahoo Finance • 3 months ago

Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 3 months ago

Stocks See Support as Investors Await Tariff News

The S&P 500 Index ($SPX) (SPY) today is up +0.66%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.64%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.83%.  September E-mini S&P futures (ESU25) are up +0.56%, and September E-mini N... Full story

Yahoo Finance • 3 months ago

Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes

Investing.com -- Citi analysts have taken action on two U.S. MedTech names, upgrading Haemonetics (NYSE:HAE) to Buy from Neutral, while downgrading Tandem Diabetes Care (NASDAQ:TNDM) to Sell/High Risk from Neutral/High Risk, citing divergi... Full story

Yahoo Finance • 3 months ago

Tandem Diabetes stock falls after Citi downgrades to Sell on competition concerns

Investing.com -- Tandem Diabetes Care (NASDAQ:TNDM) stock fell 5% Wednesday morning after Citi downgraded the medical device maker to Sell from Neutral, citing intensifying competitive pressures. Analyst Joanne Wuensch slashed the price t... Full story

Yahoo Finance • 3 months ago

Medtronic's SWOT analysis: stock poised for growth amid challenges

Medtronic PLC (NYSE:MDT), a leading global medical technology company with a market capitalization of $113.25 billion, has been navigating a complex landscape of opportunities and challenges in recent months. According to InvestingPro dat... Full story

Yahoo Finance • 3 months ago

RSI Alert: Tandem Diabetes Care (TNDM) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 3 months ago

Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids

Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech. Continue Reading View Comments... Full story